Iktos raises €15.5M to expand AI drug discovery technologies
Iktos, a company specializing in artificial intelligence (AI) for new drug discovery, has closed a…
Iktos, a company specializing in artificial intelligence (AI) for new drug discovery, has closed a…
Flagship Pioneering has created Ampersand Biomedicines, a company creating programmable medicines that are intended to…
Noema Pharma, a Swiss clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, has…
BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating life science research, has added…
By Sander Slootweg, managing partner, Forbion More than 300 million people around the globe are…
Resalis Therapeutics has completed a seed financing round of €10 million to establish a non-coding…
Panakès Partners, an Italian venture capital firm in the life sciences sector, has closed its…
Hemab Therapeutics, a clinical-stage biotechnology company developing the first prophylactic therapeutics for serious, underserved bleeding…
Biotechnology company Maxion Therapeutics has completed its $16 million Series A financing. The funds will…
BiPER Therapeutics, a French preclinical biotechnology company developing first-in-class drug candidates targeting BiP protein to…
The Estonian biopharma company Icosagen AS has reached an €18 million financing agreement with the…
TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, has closed its €22 million…